Former head of Archegos fund found guilty of fraud
Former head of Archegos fund found guilty of fraud
Keystone-SDA
Bill Hwang was found guilty in New York on Wednesday of fraud and market manipulation, in a case that shook the financial markets in 2021, especially Credit Suisse.
This content was published on
3 minutes
Keystone-SDA
Français
fr
L’ex-patron du fonds Archegos jugé coupable de fraude
Original
The jury in a Manhattan federal court upheld 10 of the 11 charges against the financier, according to several US media outlets. Theoretically, he faces up to 200 years in prison.
Archegos’ former CFO, Patrick Halligan, was found guilty on all three counts.
In the midst of the Covid-19 pandemic, Sunn Kook Hwang (real name) had, in the space of a few months, accumulated massive – and mostly concealed – positions in a number of companies.
At its peak, in March 2021, Archegos was exposed to $160 billion (approx. CHF144 billion) through derivatives, thanks to which Hwang’s company had multiplied its financial heft, but also the risks incurred.
His aim was to drive up the share prices of the few companies in which Archegos had invested, to the point of almost quadrupling the valuation of ViacomCBS (now Paramount Global) in just over four months.
At the same time, the South Korea-born American financier and three of his executives had concealed the size of their positions from the institutions that sold them these “swaps” or lent him money.
The fragile edifice collapsed when ViacomCBS announced a capital increase in March 2021, triggering a sharp sell-off on Wall Street.
This inflection triggered a domino effect, melting Archegos’ cash position at an accelerated pace and plunging the price of the shares held by the investment fund.
Around 100 billion dollars in market capitalisation was lost, hurting the other shareholders of these companies and the institutions that had done business with Archegos, mainly banks.
Credit Suisse heavily exposed
The hardest hit was Credit Suisse, which lost some $5.5 billion. All in all, the banks caught up in this whirlwind suffered losses of around $10 billion.
This event further weakened Credit Suisse, which came close to bankruptcy in March 2023 before being taken over by its Swiss rival UBS.
During the trial, the prosecution relied on two former Archegos executives who testified at the hearing, one of whom claimed that Hwang had instructed him to present a false picture of Archegos’ situation.
Lawyers for the main defendant sought unsuccessfully to discredit these testimonies, insisting that the financier had never sold his shares in order to profit from his operations.
Adapted from French by DeepL/ac
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.
If you want to know more about how we work, have a look here, if you want to learn more about how we use technology, click here, and if you have feedback on this news story please write to english@swissinfo.ch.
External Content
Your subscription could not be saved. Please try again.
Almost finished… We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.
Popular Stories
More
Climate adaptation
Why Switzerland is among the ten fastest-warming countries in the world
Has your continent reached its peak or is there still potential for economic growth?
Some regions of the world are on an upward trajectory with the promise of a steadily improving future. Where do you live? And in which direction is your region or continent developing?
Living longer: What do you think about the longevity trend?
The longevity market is booming thanks in part to advances in the science of ageing. What do you think of the idea of significantly extending human lifespan?
US tariffs: Pharma firms not planning job cuts in Switzerland
This content was published on
The additional investments in the US will not lead to a reduction in jobs in Switzerland. This is according to pharmaceutical giant Roche, which expects the number of employees to remain stable in the current year. The position of Novartis is similar.
Switzerland is closely monitoring three livestock diseases
This content was published on
The spread of Lumpy skin disease, Bluetongue and African swine fever are keeping Swiss veterinary authorities on the alert.
Swiss writer wins European Prize for Political Culture
This content was published on
On Saturday, the Hans Ringier Foundation awarded the 91-year-old Zurich writer Adolf Muschg the European Prize for Political Culture.
Swiss government working with firms to overcome high US tariffs
This content was published on
The Swiss delegation that travelled to Washington has returned from talks on tariffs in the United States. The negotiations are now being conducted under the aegis of the government and the federal administration, according to Seco.
WTO improves its world trade forecast thanks to Trump’s tariffs
This content was published on
The World Trade Organisation (WTO) expects world trade to grow by 0.9% this year, better than expected in April. US imports surged in the first quarter as a result of Donald Trump's tariff announcements.
Swiss gold exports might not face US tariffs after all
This content was published on
Gold exports to the United States may not be taxed after all. The White House plans to "issue an executive order in the near future to clarify misinformation regarding the taxation of gold bullion," among other things.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.